US Stock MarketDetailed Quotes

NVNOW ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM)

Watchlist
  • 0.0063
  • 0.00000.00%
Close May 30 09:30 ET
0Market Cap0.00P/E (TTM)

ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.04%5.35M
-2.46%6.81M
27.40%6.8M
47.59%24.93M
-28.17%6.46M
127.23%6.15M
192.79%6.99M
89.99%5.34M
84.92%16.89M
116.26%8.99M
Selling and administrative expenses
-30.28%2.55M
-33.55%2.6M
-15.36%3.2M
34.51%15.02M
-49.20%3.66M
146.90%3.66M
201.93%3.91M
221.68%3.78M
128.66%11.17M
283.33%7.21M
Research and development costs
12.28%2.8M
37.13%4.21M
131.64%3.6M
73.08%9.91M
56.96%2.8M
103.43%2.49M
181.93%3.07M
-4.90%1.55M
34.71%5.73M
-21.75%1.78M
Operating profit
13.04%-5.35M
2.46%-6.81M
-27.40%-6.8M
-47.59%-24.93M
28.17%-6.46M
-127.23%-6.15M
-192.79%-6.99M
-89.99%-5.34M
-84.92%-16.89M
-116.26%-8.99M
Net non-operating interest income expense
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
428.57%37K
66.67%5K
408.16%19K
1,492.36%5K
Non-operating interest income
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
--37K
66.67%5K
--19K
--5K
Other net income (expense)
1,547.62%304K
366.37%301K
360K
-70.52%102K
236K
-106.71%-21K
-11,400.00%-113K
8,541.08%346K
0
Gain on sale of security
1,547.62%304K
366.37%301K
--360K
--102K
--236K
---21K
---113K
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
--313K
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
---313K
--0
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
115.28%33K
--0
Income before tax
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
-80.92%-16.53M
-105.49%-8.99M
Income tax
Net income
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
-80.92%-16.53M
-105.49%-8.99M
Net income continuous Operations
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
-80.92%-16.53M
-105.49%-8.99M
Minority interest income
Net income attributable to the parent company
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
-80.92%-16.53M
-105.49%-8.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
-69.64%-16.53M
-81.31%-8.99M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.04%5.35M-2.46%6.81M27.40%6.8M47.59%24.93M-28.17%6.46M127.23%6.15M192.79%6.99M89.99%5.34M84.92%16.89M116.26%8.99M
Selling and administrative expenses -30.28%2.55M-33.55%2.6M-15.36%3.2M34.51%15.02M-49.20%3.66M146.90%3.66M201.93%3.91M221.68%3.78M128.66%11.17M283.33%7.21M
Research and development costs 12.28%2.8M37.13%4.21M131.64%3.6M73.08%9.91M56.96%2.8M103.43%2.49M181.93%3.07M-4.90%1.55M34.71%5.73M-21.75%1.78M
Operating profit 13.04%-5.35M2.46%-6.81M-27.40%-6.8M-47.59%-24.93M28.17%-6.46M-127.23%-6.15M-192.79%-6.99M-89.99%-5.34M-84.92%-16.89M-116.26%-8.99M
Net non-operating interest income expense -41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K428.57%37K66.67%5K408.16%19K1,492.36%5K
Non-operating interest income -41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K--37K66.67%5K--19K--5K
Other net income (expense) 1,547.62%304K366.37%301K360K-70.52%102K236K-106.71%-21K-11,400.00%-113K8,541.08%346K0
Gain on sale of security 1,547.62%304K366.37%301K--360K--102K--236K---21K---113K------------
Special income (charges) --------------0------------------313K--0
-Less:Other special charges -----------------------------------313K--0
Other non- operating income (expenses) --------------------------------115.28%33K--0
Income before tax 17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M-80.92%-16.53M-105.49%-8.99M
Income tax
Net income 17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M-80.92%-16.53M-105.49%-8.99M
Net income continuous Operations 17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M-80.92%-16.53M-105.49%-8.99M
Minority interest income
Net income attributable to the parent company 17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M-80.92%-16.53M-105.49%-8.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M-69.64%-16.53M-81.31%-8.99M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg